Use of Oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases

Circulation: Cardiovascular Quality and Outcomes

Volumn 2, Issue 2, 2009, Pages 108-115

  Casscells, S Ward ^a   Granger, Elder ^b   Kress, Amii M ^b   Linton, Andrea ^a   Madjid, Mohammad ^d   Cottrell, Linda ^c  

^a Health Affairs   (United States)

^b Office of the Assistant Secretary of Defense (Health Affairs)   (United States)

^c Health Program Analysis and Evaluation   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Complications; Epidemiology; Follow up studies; Prevention

Indexed keywords

OSELTAMIVIR; ZANAMIVIR; ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; INCIDENCE; INFLUENZA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; FOLLOW UP; GOVERNMENT; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENT DISEASE; RISK FACTOR; SOLDIER; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADULT; AGED; ANTIVIRAL AGENTS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MILITARY PERSONNEL; MULTIVARIATE ANALYSIS; OSELTAMIVIR; RECURRENCE; RISK FACTORS; UNITED STATES; UNITED STATES GOVERNMENT AGENCIES;

EID: 70349192005     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.108.820357     Document Type: Article

References (30)

1. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet. 1998; 351: 1467-1471. (Pubitemid 28227037)
2. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004; 351: 2611-2618. (Pubitemid 39628582)
3. Madjid M, Miller CC, Zarubaev VV, Marinich IG, Kiselev OI, Lobzin YV, Filippov AE, Casscells SW. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34, 892 subjects. Eur Heart J. 2007; 28: 1205-1210. (Pubitemid 47343835)
4. Housworth J, Langmuir AD. Excess mortality from epidemic influenza, 1957-1966. Am J Epidemiol. 1974; 100: 40-48.
5. Alling DW, Blackwelder WC, Stuart-Harris CH. A study of excess mortality during influenza epidemics in the United States 1968-1976. Am J Epidemiol. 1981; 113: 30-43.
6. Madjid M, Casscells SW. Of birds and men: cardiologists' role in influenza pandemics. Lancet. 2004; 364: 1309. (Pubitemid 39335815)
7. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007; 56 (RR-6) : 1-54. Available at: http://www.medscape.com/medline/abstract/11334444?src=emed-ckb-ref-0. Accessed March 28, 2008.
8. AHA; ACC; National Heart, Lung, and Blood Institute, Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pearson T. Pfeffer MA, Taubert KA. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update Endorsed by the National Heart Lung, and Blood Institute. J Am Coll Cardiol. 2006; 47: 2130-2139. (Pubitemid 44275145)
9. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003; 348: 1322-1332. (Pubitemid 36384099)
10. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells SW. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 2000; 102: 3039-3045.
11. Grau AJ, Fischer B, Barth C, Ling P, Lichy C, Buggle F. Influenza vaccination is associated with a reduced risk of stroke. Stroke. 2005;36:1501-1506. (Pubitemid 40967520)
12. Madjid M, Naghavi M, Litovsky S, Casscells SW. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation. 2003; 108: 2730-2736. (Pubitemid 37498972)
13. Singh S, Barghoorn J, Bagdonas A, Adler J, Treanor J, Kinnersley N, Ward P. Clinical benefits with oseltamivir in treating influenza in adult populations: results of a pooled and subgroup analysis. Clin Drug Investig. 2003; 23: 561-569. (Pubitemid 37115072)
14. Abe M, Smith J, Urae A, Barrett J, Kinoshita H, Rayner CR. Pharmacokinetics of oseltamivir in young and very elderly subjects. Ann Pharmacother. 2006; 40: 1724-1730. (Pubitemid 44544867)
15. Moscona A. Neuraminidase inhibitors for influenza. Engl J Med. 2005;353:1363-1373. (Pubitemid 41362704)
16. Blumentals WA, Schulman KL. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study. Curr Med Res Opin. 2007; 23: 2961-2970.
17. Orzeck EA, Shi N, Blumentals WA. Oseltamivir and the risk of influenzarelated complications and hospitalizations in patients with diabetes. Clin Ther. 2007; 29: 2246-2255. (Pubitemid 350138559)
18. Enger C, Nordstrom BL, Thakrar B, Sacks S, Rothman KJ. Health outcomes among patients receiving oseltamivir. Pharmacoepidemiol Drug Saf. 2004; 13: 227-237. (Pubitemid 38514836)
19. Blumentals WA, Song X. The safety of oseltamivir in patients from influenza: analysis of healthcare claims from six influenza seasons. Med-GenMed. 2007; 9: 23. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi? tool = pubmed&pubmedid= 18311373. Accessed March 3, 2008. (Pubitemid 350031662)
20. Nordstrom BL, Oh K, Sacks ST, L'Italien GJ. Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study. Antivir Ther. 2004; 9: 187-195. (Pubitemid 38560211)
21. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner DA, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ. 2003; 326: 1235. (Pubitemid 36688077)
22. Leslie S, Thiebaud P. Using Propensity Scores to Adjust For Treatment Selection Bias. Proceedings of the SAS® Global Forum 2007 Conference. Cary, NC: SAS Institute Inc; 2007. Available at: http://www2.sas.com/proceedings/ forum2007/184-2007.pdf. Accessed December 1, 2008.
23. Bowles SK, Lee W, Simor AE, Vearncombe M, Loeb M, Tamblyn S, Fearon M, McGeer A; Oseltamivir Compassionate Use Program Group. Use of eseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. Cardiovascular Disease Statistics. © 2008 American Heart Association, Inc. Available at: http://www.americanheart.org/presenter.jhtml?identifier=4478. Accessed May 29, 2008.
24. Rothberg MB, Bellantonio S, Rose DN. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Ann Intern Med. 2003; 139: 321-329.
25. Madjid M, Aboshady I, Awan I, Litovsky S, Casscells SW. Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J. 2004; 31: 4-13.
26. Musher DM, Rueda AM, Kaka AS, Mapara SM. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007; 45: 158-165.
27. Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, Dunbar S, Drumholz HM; American Heart Association; American College of Cardiology; American Association of Cardiovascular and Pulmonary Rehabilitation; American Association of Critical Care Nurses; American Association of Heart Failure Nurses; American Diabetes Association; Association of Black Cardiologists, Inc; Heart Failure Society of America; Preventive Cardiovascular Nurses Association; American Academy of Nurse Practitioners; Centers for Disease Control and Prevention and the Advisory Committee on Immunization. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol. 2006; 48: 1498-1502.
28. Linton A, Peterson MR, William TV. Effects of maternal characteristics on cesarean delivery rates among U. S. Department of Defense health care beneficaries, 1996-2002. Birth. 2004; 31: 3-11.
29. United States Department of Health and Human Services. HHS Pandemic Influenza Plan Supplement 7 Antiviral Drug Distribution and Use. Available at: http://www.hhs.gov/pandemicflu/plan/sup7.html. Accessed March 14, 2007.
30. Singer AC, Nunn MA, Gould EA, Johnson AC. Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect. 2007; 115: 102-106.